Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Security class unavailable · CUSIP: 53220K504
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,847,210
- Percent of class
- 10.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-20-000002
- Form type
- SC 13G
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Jan 10, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership